Merit Medical Systems, Inc.

How big is Merit Medical Systems, Inc.?

As of Jun 18, Merit Medical Systems, Inc. has a market capitalization of $5.49 billion, with net sales of $1.39 billion and a net profit of $122.27 million over the last four quarters.

Market Cap: As of Jun 18, Merit Medical Systems, Inc. has a market capitalization of 5,490.35 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Merit Medical Systems, Inc. reported net sales of 1,385.62 million and a net profit of 122.27 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,379.36 million and total assets of 2,418.60 million.

What does Merit Medical Systems, Inc. do?

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures, with a market cap of approximately $5.49 billion and quarterly net sales of $354 million. Key financial metrics include a P/E ratio of 42.00 and a return on equity of 9.28%.

Overview:<BR>Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in interventional, diagnostic, and therapeutic medical procedures, operating in the Pharmaceuticals & Biotechnology industry with a small-cap market classification.<BR><BR>Financial Snapshot:<BR>- Net Sales: 354 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: 30 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 5,490.35 Million (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 42.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.24<BR>- Return on Equity: 9.28%<BR>- Price to Book: 3.84<BR><BR>Contact Details:<BR>- Address: 1600 W Merit Pkwy, SOUTH JORDAN UT: 84095-2416<BR>- Tel: ['1 801 2531600', '1 801 2084167']<BR>- Fax: 1 801 2531652<BR>- Website: https://www.merit.com/

Should I buy, sell or hold Merit Medical Systems, Inc.?

Who are in the management team of Merit Medical Systems, Inc.?

As of March 2022, the management team of Merit Medical Systems, Inc. includes Mr. Fred Lampropoulos as Chairman, President, and CEO, with Ms. Lynne Ward and several Independent Directors on the Board, including Mr. A. Scott Anderson, Ms. Jill Anderson, Mr. Thomas Gunderson, and Dr. F. Ann Millner.

As of March 2022, the management team of Merit Medical Systems, Inc. includes Mr. Fred Lampropoulos, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the Board of Directors features Ms. Lynne Ward as a Director, along with several Independent Directors: Mr. A. Scott Anderson, Ms. Jill Anderson, Mr. Thomas Gunderson, and Dr. F. Ann Millner.

Is Merit Medical Systems, Inc. overvalued or undervalued?

As of October 17, 2025, Merit Medical Systems, Inc. is considered overvalued with a valuation grade of expensive, reflected by its high P/E ratio of 42 and underperformance of -15.36% year-to-date compared to the S&P 500's 13.30% return.

As of 17 October 2025, the valuation grade for Merit Medical Systems, Inc. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 42, a Price to Book Value of 3.94, and an EV to EBITDA of 20.38, all of which suggest a premium valuation compared to its peers. <BR><BR>In comparison, Masimo Corp. has a significantly higher P/E ratio of 179.74, while Lantheus Holdings, Inc. presents a much lower P/E of 10.13, highlighting the disparity in valuations within the sector. The recent stock performance shows that Merit Medical has underperformed against the S&P 500 year-to-date, with a return of -15.36% compared to the S&P 500's 13.30%, reinforcing the notion that the stock may be overvalued at its current price.

Is Merit Medical Systems, Inc. technically bullish or bearish?

As of October 31, 2025, Merit Medical Systems, Inc. is in a mildly bearish trend, with mixed technical indicators showing short-term outperformance against the S&P 500 but a year-to-date underperformance.

As of 31 October 2025, the technical trend for Merit Medical Systems, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly chart. Bollinger Bands indicate a mildly bullish stance weekly, while they are bearish monthly. Daily moving averages are mildly bearish, and the KST reflects a mildly bullish signal weekly but is mildly bearish monthly. There are no clear trends indicated by Dow Theory or OBV.<BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 6.91% and 5.06% respectively, while it has underperformed over the longer term, with a year-to-date return of -8.53% compared to the S&P 500's 16.30%.